Skip to main content
. 2016 Sep 2;11(9):e0161801. doi: 10.1371/journal.pone.0161801

Table 1. Sequencing data overview of three camel samples.

Sample ID Raw data Clean Data (%) Merged (%) V-align (%) J-align (%) VJ-align (%) Effective data Effective data/raw data (%)
1-VH 585688 74.3 92.09 71.31 91.66 70.46 351209 59.97
1-VHH 610474 66.74 91.71 53.27 90.82 52.54 309782 50.74
2-VH 461284 73.69 92.47 70.18 91.72 69.29 272373 59.05
2-VHH 540738 64.22 91.71 53.67 91.21 52.82 266320 49.25
3-VH 544848 75.67 91.95 58.02 88.69 57.33 310279 56.95
3-VHH 573617 71.64 91.12 45.52 90.02 44.84 292751 51.04

Sample ID: “1-VH” and “1-VHH” represent the NO.1 camel`s conventional antibody and nanobody clones, respectively. The same nomenclature is used in the other samples. Raw data are the total number of reads; Clean data (%) is the rate of the filtered sequence reads, with the low-quality data removed; Merged (%) is the percent of sequences generated by merging the pair-end reads to one intact read; V-align (%), J-align (%) and VJ-align (%) are percentages of the sequencing data that were matched with the IMGT reference sequences; Effective data are the number of reads after filtering; Effective data/raw data (%) is the percent of raw data that remained after filtering.